Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease.
Mol Genet Metab
; 125(1-2): 153-160, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-30054149
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fabry Disease
/
Alpha-Galactosidase
/
Biosimilar Pharmaceuticals
/
Isoenzymes
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Mol Genet Metab
Journal subject:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
/
METABOLISMO
Year:
2018
Document type:
Article
Affiliation country:
Japan